Skip to Main Content

Paper Details

Plasma AR and abiraterone-resistant prostate cancer.
Sci Transl Med
343
2015
AR, AR coding, AR coding bases, AR gene, Androgen, Androgen receptor, Androgen receptor (AR) gene, L702H, L702H AR, PSA, Patients, Plasma AR, T878A, abiraterone-resistant prostate cancer, amino acid, cancers, castration-resistant prostate cancer, genomic regions, mutant AR alleles, normal DNA, patients, plasma, plasma DNA, prostate cancer, prostate-specific antigen, tumor, tumor DNA, tumors
Author NameAffiliation
Alessandro RomanelUniversity of Trento
Alessandro RomanelUniversity of Trento
Zafeiris ZafeiriouThe Institute of Cancer Research, UK. The Royal Marsden NHS Foundation Trust
Suzanne CarreiraThe Institute of Cancer Research
Roberta FerraldeschiThe Institute of Cancer Research, UK. The Royal Marsden NHS Foundation Trust
Nina TunariuThe Institute of Cancer Research, UK. The Royal Marsden NHS Foundation Trust
Penny FlohrThe Institute of Cancer Research
Johann S de BonoThe Institute of Cancer Research, UK. The Royal Marsden NHS Foundation Trust
Francesca DemichelisUniversity of Trento, Italy. Institute for Computational Biomedicine, USA. Institute for Precision Medicine
Francesca DemichelisUniversity of Trento, Italy. Institute for Computational Biomedicine, USA. Institute for Precision Medicine
Gerhardt AttardThe Institute of Cancer Research, UK. The Royal Marsden NHS Foundation Trust
  • 1 - 11

Datasets

Release 1.2